Variant report
Variant | nsv613891 |
---|---|
Chromosome Location | chr9:25253996-25301050 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TUSC1-1 | chr9:25290336-25290489 | NONHSAT130499 |
2 | lnc-TUSC1-1 | chr9:25288488-25288555 | NONHSAT130499 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000198680 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1372870 | chr9:25253996-25253997 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs192876241 | chr9:25254060-25254061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540779180 | chr9:25254125-25254126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368190466 | chr9:25254143-25254144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560693744 | chr9:25254145-25254146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574183036 | chr9:25254150-25254151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144078368 | chr9:25254230-25254231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563270976 | chr9:25254245-25254246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531980092 | chr9:25254270-25254271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183111275 | chr9:25254347-25254348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552061586 | chr9:25254363-25254364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150700351 | chr9:25254390-25254391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111400353 | chr9:25254405-25254406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548001887 | chr9:25254415-25254416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149836314 | chr9:25254443-25254444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546065068 | chr9:25254473-25254474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2383500 | chr9:25254483-25254484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2383501 | chr9:25254484-25254485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs68165298 | chr9:25254505-25254506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377498221 | chr9:25254506-25254507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs57761907 | chr9:25254513-25254514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1662231 | chr9:25254515-25254516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546209190 | chr9:25254518-25254519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs117920933 | chr9:25254520-25254521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147264988 | chr9:25254531-25254532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372022384 | chr9:25254532-25254533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3059275 | chr9:25254540-25254541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73642317 | chr9:25254554-25254555 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs375688305 | chr9:25254559-25254560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538613543 | chr9:25254573-25254574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139868507 | chr9:25254588-25254589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565634808 | chr9:25254664-25254665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115346117 | chr9:25254674-25254675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143137901 | chr9:25254685-25254686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116031231 | chr9:25254690-25254691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543522468 | chr9:25254725-25254726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556743044 | chr9:25254742-25254743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576778983 | chr9:25254832-25254833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372792671 | chr9:25254909-25254910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73642318 | chr9:25254912-25254913 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs375871266 | chr9:25254937-25254938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75979480 | chr9:25254958-25254959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73642319 | chr9:25254965-25254966 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs541674479 | chr9:25254972-25254973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561489766 | chr9:25255001-25255002 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374150293 | chr9:25255016-25255017 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550256548 | chr9:25255017-25255018 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184760958 | chr9:25255020-25255021 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532584248 | chr9:25255024-25255025 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552141076 | chr9:25255043-25255044 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Lung cancer | 21569311 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Cancer | 21215367 | CNVD |
Chordoma | 21215367 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:25253200-25254000 | Enhancers | Fetal Brain Female | brain |
2 | chr9:25253400-25255800 | Enhancers | Fetal Brain Male | brain |
3 | chr9:25254000-25254600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr9:25255000-25255400 | Active TSS | HSMM | muscle |
5 | chr9:25259000-25260200 | Enhancers | Fetal Kidney | kidney |
6 | chr9:25260200-25265000 | Weak transcription | Fetal Kidney | kidney |
7 | chr9:25265000-25268000 | Active TSS | Fetal Kidney | kidney |
8 | chr9:25266800-25267200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr9:25283600-25283800 | Enhancers | Fetal Lung | lung |
10 | chr9:25283800-25284600 | Weak transcription | Fetal Lung | lung |
11 | chr9:25284600-25285400 | Enhancers | Fetal Lung | lung |
12 | chr9:25286600-25288200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr9:25287800-25288200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr9:25288000-25288200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr9:25289200-25291200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:25291800-25292000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr9:25292000-25292400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr9:25292400-25295600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr9:25295400-25296200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr9:25295600-25296000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr9:25295600-25296000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |